A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

A new experimental pancreatic cancer drug called Daraxonrasib is generating major excitement among oncologists after clinical trials showed it could nearly double survival in patients with advanced ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation’s deadliest diseases.

A new pill could be the future of treatment late-stage pancreatic cancer in the U.S., nearly doubling the length patients live compared to those on chemotherapy, clinical oncology company Revolution ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...

An experimental pill to treat metastatic pancreatic cancer almost doubled patients’ survival times compared with chemotherapy. The drug isn’t Food and Drug Administration approved, so it’s not readily ...

Clinical worker John McNeur didn't realise he was unwell until he was delivering a health workshop on pancreatic cancer in the remote Northern Territory — and he began ticking all of the boxes. Now he ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final subject has received their first dose in the Phase 2 DURIPANC clinical trial evaluating Ampligen® ...